The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study
A Zaphiriou, S Robb, T Murray‐Thomas… - European journal of …, 2005 - Wiley Online Library
Objectives To determine the diagnostic accuracy of the measurement of plasma B‐type
natriuretic peptide (BNP) and N‐terminal pro‐BNP (NTproBNP) in patients referred by their …
natriuretic peptide (BNP) and N‐terminal pro‐BNP (NTproBNP) in patients referred by their …
Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non–ST-segment elevation myocardial infarction …
JC Tardif, JF Tanguay, SR Wright, V Duchatelle… - Journal of the American …, 2013 - jacc.org
Objectives: The study aimed to evaluate inclacumab for the reduction of myocardial damage
during a percutaneous coronary intervention (PCI) in patients with non–ST-segment …
during a percutaneous coronary intervention (PCI) in patients with non–ST-segment …
The index of microcirculatory resistance measured acutely predicts the extent and severity of myocardial infarction in patients with ST-segment elevation myocardial …
R McGeoch, S Watkins, C Berry, T Steedman… - JACC: Cardiovascular …, 2010 - jacc.org
Objectives: This study investigated the relationship between the index of microcirculatory
resistance (IMR) with myocardial injury and microvascular obstruction (MVO) assessed by …
resistance (IMR) with myocardial injury and microvascular obstruction (MVO) assessed by …
Retrospective analysis of thecost-effectiveness of using plasmabrain natriuretic peptide inscreening for left ventricularsystolic dysfunction in the general population
OW Nielsen, TA McDonagh, SD Robb… - Journal of the American …, 2003 - jacc.org
Objectives: We sought to assess the cost-effectiveness of using plasma brain natriuretic
peptide (BNP) as a pre-echocardiographic screening test for left ventricular systolic …
peptide (BNP) as a pre-echocardiographic screening test for left ventricular systolic …
Effects of the P‐selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention according to timing of infusion: insights from the …
BE Stähli, C Gebhard, V Duchatelle… - Journal of the …, 2016 - Am Heart Assoc
Background The Effects of the P‐Selectin Antagonist Inclacumab on Myocardial Damage
After Percutaneous Coronary Intervention for Non‐ST‐Segment Elevation Myocardial …
After Percutaneous Coronary Intervention for Non‐ST‐Segment Elevation Myocardial …
Efficacy and safety of bevacizumab-containing therapy in newly diagnosed ovarian cancer: ROSiA single-arm phase 3B study
AM Oza, F Selle, I Davidenko, J Korach… - International Journal of …, 2017 - ijgc.bmj.com
Objective The aim of this study was to assess the safety and efficacy of extending
bevacizumab therapy beyond 15 months in nonprogressive ovarian cancer. Patients and …
bevacizumab therapy beyond 15 months in nonprogressive ovarian cancer. Patients and …
[HTML][HTML] Real-world treatment patterns and clinical outcomes in patients with stage III NSCLC: results of KINDLE, a multicountry observational study
Abstract Introduction Stage III NSCLC is a heterogeneous disease requiring a multimodal
management approach. We conducted a real-world, global study to characterize patients …
management approach. We conducted a real-world, global study to characterize patients …
Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice
DR Murdoch, J Byrne, JJ Morton, TA McDonagh… - Heart, 1997 - heart.bmj.com
Objectives To compare the stability of brain natriuretic peptide (BNP) to that of N-terminal
atrial natriuretic peptide (NT-ANP) in whole blood and plasma stored under different …
atrial natriuretic peptide (NT-ANP) in whole blood and plasma stored under different …
[HTML][HTML] Effects of P-selectin antagonist inclacumab in patients undergoing coronary artery bypass graft surgery: SELECT-CABG trial
BE Stähli, JC Tardif, M Carrier, R Gallo… - Journal of the American …, 2016 - jacc.org
Please note: This work was supported by a grant from the Société Française de Cardiologie.
Dr. Clementy has received funding for conference travel and educational symposia from …
Dr. Clementy has received funding for conference travel and educational symposia from …
Cancer cell detection device for the diagnosis of bladder cancer from urine
Bladder cancer is common and has one of the highest recurrence rates. Cystoscopy, the
current gold standard diagnosis approach, has recently benefited from the introduction of …
current gold standard diagnosis approach, has recently benefited from the introduction of …